Cargando…
Selective Targeting of Human and Animal Pathogens of the Helicobacter Genus by Flavodoxin Inhibitors: Efficacy, Synergy, Resistance and Mechanistic Studies
Antimicrobial resistant (AMR) bacteria constitute a global health concern. Helicobacter pylori is a Gram-negative bacterium that infects about half of the human population and is a major cause of peptic ulcer disease and gastric cancer. Increasing resistance to triple and quadruple H. pylori eradica...
Autores principales: | Salillas, Sandra, Galano-Frutos, Juan José, Mahía, Alejandro, Maity, Ritwik, Conde-Giménez, María, Anoz-Carbonell, Ernesto, Berlamont, Helena, Velazquez-Campoy, Adrian, Touati, Eliette, Mamat, Uwe, Schaible, Ulrich E., Gálvez, José A., Díaz-de-Villegas, María D., Haesebrouck, Freddy, Aínsa, José A., Sancho, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467567/ https://www.ncbi.nlm.nih.gov/pubmed/34576300 http://dx.doi.org/10.3390/ijms221810137 |
Ejemplares similares
-
Flavodoxins as Novel Therapeutic Targets against Helicobacter pylori and Other Gastric Pathogens
por: Salillas, Sandra, et al.
Publicado: (2020) -
Alchemical Design of Pharmacological Chaperones with Higher Affinity for Phenylalanine Hydroxylase
por: Conde-Giménez, María, et al.
Publicado: (2022) -
Streptococcus pneumoniae TIGR4 Flavodoxin: Structural and Biophysical Characterization of a Novel Drug Target
por: Rodríguez-Cárdenas, Ángela, et al.
Publicado: (2016) -
In silico discovery and biological validation of ligands of FAD synthase, a promising new antimicrobial target
por: Lans, Isaias, et al.
Publicado: (2020) -
Discovery of antimicrobial compounds targeting bacterial type FAD synthetases
por: Sebastián, María, et al.
Publicado: (2017)